Posts Tagged: copaxone
Other Barks & Bites for Wednesday, February 1st, 2017
This week, a patent battle between two American tech giants expands its scope to China, patents covering a well-known multiple sclerosis treatment were invalidated in U.S. …
PTAB invalidates three patents covering Teva’s Copaxone, opens door for Mylan’s generic version
On Wednesday, August 24th, the Patent Appeal and Trial Board (PTAB) issued decisions in two inter partes review (IPR) filings made against patents owned by private Israeli …
Pharma Update: News for April 2014
What follows below is a review of some of the pharma news stories that caught my attention during the month of April 2014. Supreme Court Denies Teva's Request …
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®
Teva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), …
